Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Hungary's Olivér Várhelyi readies to be EU health commissioner, pledging major pharma support
6 months ago
Pharma
Law
House Republicans push for more transparency on government-funded trial data
6 months ago
Pharma
FDA+
Iterum wins approval for new oral antibiotic for UTIs. Now it wants a partner
6 months ago
Pharma
FDA+
Telix's new radiopharma spinout banks on one trial for success, CEO says
6 months ago
Startups
Manufacturing
Post-Hoc: Novo’s obesity enemies
6 months ago
Editor's note
Pharma
Tyra's stock dips as it gives first look in challenge to J&J’s bladder cancer drug Balversa
6 months ago
R&D
Lyell Immunopharma to acquire ImmPACT Bio, cut top programs
6 months ago
Deals
Cell/Gene Tx
Bristol Myers, Ideaya tout data in solid tumors with certain genetic mutations
6 months ago
R&D
EnGene’s $60M PIPE; AbbVie to develop neuropsychiatric drugs with Gedeon Richter
6 months ago
News Briefing
Elucida Oncology, seeking foothold in ADCs, shutters due to 'lack of funding'
6 months ago
People
Startups
Septerna bags $288M upsized IPO for GPCR drugs
6 months ago
Financing
Startups
Chinook alums reunite following exit to Novartis; The first board appointment for Recursion’s Chris Gibson
6 months ago
Peer Review
GSK to spend $800M to build two vaccine factories in the US
6 months ago
Manufacturing
Sanofi reports sales jump for Beyfortus as RSV antibody challenger from Merck nears
6 months ago
Pharma
Sanofi backs fibrosis biotech Agomab as it raises $89M Series D
6 months ago
Financing
Startups
CDC advisors decline to recommend RSV shots to younger at-risk adults, affirming prior guidance
6 months ago
Pharma
FDA+
BridgeBio shares promising results in trial of Canavan disease gene therapy
6 months ago
R&D
Cell/Gene Tx
Icon's quarterly earnings hit by biotech and pharma pullback
6 months ago
R&D
Outsourcing
Lonza extends contract with unnamed pharma; Rentschler's new build
6 months ago
Manufacturing
Roche returns to Dyno for its AAV tech with $50M upfront
6 months ago
Deals
Cell/Gene Tx
Marinus plans another round of layoffs, cost cuts following Phase 3 fail
6 months ago
R&D
Zai Lab unveils early lung cancer data as it looks to challenge Amgen's Imdelltra
6 months ago
R&D
Bayer, Dewpoint to work on heart drug; Viking’s obesity manufacturing plans
6 months ago
News Briefing
Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots
6 months ago
Pharma
Health Tech
First page
Previous page
74
75
76
77
78
79
80
Next page
Last page
